Hologic (NASDAQ: HOLX) notifies Nasdaq of listing withdrawal

Rhea-AI Filing Summary

Hologic Inc. filed a Form 25 notifying the Nasdaq Stock Market LLC of the removal/withdrawal of its Common Stock from listing and registration. The notification is executed by Nasdaq (Commission File Number 001-36214) and cites compliance with 17 CFR 240.12d2-2 rules.

Key Figures

Commission File Number: 001-36214 Form expiration / reference date: March 31, 2018 Issuer telephone: (508) 263-2900

3 metrics

Commission File Number 001-36214 Form 25 cover identification

Form expiration / reference date March 31, 2018 Expires date block on the filing

Issuer telephone (508) 263-2900 Issuer principal executive office contact

Key Terms

Form 25, 17 CFR 240.12d2-2, withdrawal of listing

3 terms

Form 25 regulatory

"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.

17 CFR 240.12d2-2 regulatory

"Pursuant to 17 CFR 240.12d2-2(b) ... 17 CFR 240.12d2-2(c)"

withdrawal of listing financial

"voluntary withdrawal of the class of securities from listing and registration"

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36214

Issuer:	HOLOGIC INC
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	250 Campus Drive
	Marlborough	MASSACHUSETTS	01752
Telephone number:					(508) 263-2900

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-04-07	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Hologic (HOLX) file a Form 25?

Answer: To notify Nasdaq of the removal/withdrawal of Hologic's Common Stock from listing and registration. The filing states Nasdaq and the issuer complied with 17 CFR 240.12d2-2 procedures governing voluntary withdrawal.

Does this Form 25 mean Hologic (HOLX) will stop trading?

Answer: The filing notifies removal from Nasdaq listing/registration, but it does not state current trading status. It certifies compliance with Nasdaq rules; further filings would state post-withdrawal trading arrangements.

Who signed the Form 25 for Nasdaq in the Hologic (HOLX) filing?

Answer: The Form 25 is signed on behalf of Nasdaq by Tara Petta, AVP. The filing includes Nasdaq's certification that it has reasonable grounds to file the notification.

What regulation does the Form 25 cite in the Hologic (HOLX) filing?

Answer: The notice cites 17 CFR 240.12d2-2 (subsections (a) and (c)), the Exchange Act rule governing removal and voluntary withdrawal from listing and registration.

Where is Hologic's principal executive office listed in the Form 25?

Answer: The filing lists Hologic's address as 250 Campus Drive, Marlborough, Massachusetts 01752 and telephone (508) 263-2900 as the issuer's principal executive office contact information.